Emerging Trends to Drive Sickle Cell Disease Treatment Market Growth at 17.7% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Sickle Cell Disease Treatment Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, there has been a swift expansion in the market size for the treatment of sickle cell disease. The market valuation is expected to surge from $2.95 billion in 2024 to $3.54 billion in 2025, marking a compound annual growth rate (CAGR) of 19.7%. The significant growth experienced during the historic period is attributed to advances in understanding the disease, use of blood transfusions, implementation of pain management strategies, and hydroxyurea therapy applications.

How Will the Sickle Cell Disease Treatment Market Size Evolve and Grow by 2029?
In the ensuing years, the market size for sickle cell disease treatment is predicted to witness a surge. By 2029, it is estimated to reach $6.8 billion, growing at a compound annual growth rate (CAGR) of 17.7%. This anticipated expansion in the forecast period can be credited to factors like gene editing and gene therapy, the development of new drugs, the introduction of telemedicine and remote monitoring, and worldwide health initiatives. Key trends for the forecast phase entail curative therapies, alternatives for pain management, international collaborations, and patient advocacy and participation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report

What Drivers Are Propelling the Growth of Sickle Cell Disease Treatment Market Forward?
The sickle cell disease treatment market is predicted to grow as a result of the rising need for blood transfusions. A blood transfusion is a procedure where blood, or blood products, are transferred from a donor to a recipient. This procedure is fundamental for sickle cell disease (SCD) patients as it improves the blood's oxygen-carrying capability and reduces the issues with vaso-occlusion. Mid-Atlantic Long-Term Care, a US-based 24-hour triage on-call service, reported in January 2022 that the US requires about 29,000 units of red blood cells, 5,000 units of platelets, and 6,500 units of plasma daily. Hence, this escalating demand for blood transfusions is stimulating the expansion of the sickle cell disease treatment market. Sickle Cell Disease Treatment Market Driver: Rising Blood And Bone Marrow Transplants Accelerating the Growth of The Sickle Cell Disease Treatment Market

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp

Which Emerging Trends Are Transforming the Sickle Cell Disease Treatment Market in 2025?
Firms in the sickle cell disease treatment market, notably major players, are channeling their efforts into the creation of novel oral suspension medications. These initiatives aim to enhance patient adherence, improve drug efficacy, and extend more user-friendly treatment options, principally for pediatric and elderly subjects. Oral suspension medications are liquids with solid particles dispersed, devised to simplify intake for patients, especially the young ones or those dealing with difficulties with tablets. For example, in March 2024, Akums Drugs and Pharmaceuticals Ltd., a pharmaceutical preparation manufacturer from India, introduced a Hydroxyurea oral suspension stable at room temperature. This treatment for SCD is economically accessible and stable at room temperature, thus extending patient accessibility in India. With a price tag below 1% of imported alternatives, it allows for exact dosing via oral syringes, benefitting patients from all age groups without necessitating cold storage.

What Are the Key Segments in the Sickle Cell Disease Treatment Market?
The sickle cell disease treatment market covered in this report is segmented -

1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant
2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Blood Transfusion: Regular Blood Transfusion, Exchange Transfusion
2) By Pharmacotherapy: Hydroxyurea, L-Glutamine, Voxelotor, Crizanlizumab
3) By Bone Marrow Transplant: Allogeneic Transplant, Autologous Transplant

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13048&type=smp

Who Are the Key Players Shaping the Sickle Cell Disease Treatment Market's Competitive Landscape?
Major companies operating in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Silver Lake Research Corporation0.45, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Arena Pharmaceuticals Inc., Mast Therapeutics Inc.

What Geographic Markets Are Powering Growth in the Sickle Cell Disease Treatment Market?
North America was the largest region in the sickle cell disease treatment market in 2024. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13048

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.